Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Brain Research|September 21, 1979
Effects of anti-white matter serum on myelin and lipid synthesis in brain prismsE P Lapin, H S Maker, G M Lehrer, et al.
The Journal of Clinical Investigation|April 1, 1987
Transketolase abnormality in cultured fibroblasts from familial chronic alcoholic men and their male offspringA B Mukherjee, S Svoronos, A Ghazanfari, et al.
Neurology|December 1, 1985
Immunogenic potentials of copolymer I in normal human lymphocytesC F Brosnan, M Litwak, P A Neighbour, et al.
Health Promotion Practice|March 6, 2019
Physical Activity Communication: A Scoping Review of the LiteratureCaroline D Bergeron, Andrea H Tanner, Daniela B Friedman, et al.
Neurology|April 1, 1991
A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosisM B Bornstein, A Miller, S Slagle, et al.
Cell Death and Differentiation|August 27, 2011
The IAP-antagonist ARTS initiates caspase activation upstream of cytochrome C and SMAC/DiabloN Edison, D Zuri, I Maniv, et al.
Progress in Cardiovascular Diseases|October 24, 2022
A state-by-state and regional analysis of the direct medical costs of treating musculoskeletal injuries among US Army traineesDaniel B Bornstein, Ryan S Sacko, Sybil Prince Nelson, et al.
The New England Journal of Medicine|August 13, 1987
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosisM B Bornstein, A Miller, S Slagle, et al.
Cancer|March 4, 2000
The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapyA L Abner, J L Connolly, A Recht, et al.
Neurology|July 1, 1988
Clinical experience with COP-1 in multiple sclerosisM B Bornstein, A Miller, S Slagle, et al.
Pageof 13